Potential anxiolytic and antidepressant effects of the selective 5-HT7 receptor antagonist SB 269970 after intrahippocampal administration to rats

European Journal of Pharmacology

Volumn 553, Issue 1-3, 2006, Pages 185-190

  Wesołowska, Anna ^a   Nikiforuk, Agnieszka ^a   Stachowicz, Katarzyna ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

(Rat); 5 HT7 receptor antagonist; Drinking conflict test; Forced swimming test; Intrahippocampal injection

Indexed keywords

3 [2 [2 (4 METHYL 1 PIPERIDINYL)ETHYL] 1 PYRROLIDINESULFONYL]PHENOL; DIAZEPAM; IMIPRAMINE; SEROTONIN 7 RECEPTOR; SEROTONIN ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRINKING; EXPLORATORY BEHAVIOR; FLUID INTAKE; FORCED SWIMMING TEST; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIVITY AND SPECIFICITY; SHOCK; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CONFLICT (PSYCHOLOGY); DIAZEPAM; DRINKING BEHAVIOR; ELECTROSHOCK; HIPPOCAMPUS; IMIPRAMINE; MALE; MICROINJECTIONS; MOTOR ACTIVITY; PHENOLS; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; SULFONAMIDES; SWIMMING;

EID: 33751175401     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.09.064     Document Type: Article

References (53)

1. Bard J.A., Zgombick J., Adham N., Vaysse P., Branchek T.A., and Weinshank R.L. Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase. J. Biol. Chem. 268 (1993) 23422-23426
2. Bickmeyer U., Heine M., Manzke T., and Richter D.W. Differential modulation of I(h) by 5-HT receptors in mouse CA1 hippocampal neurons. Eur. J. Neurosci. 16 (2002) 209-218
3. 1A/1B double-knockout mice. J. Pharmacol. Exp. Ther. 302 (2002) 240-248
4. Borsini F. Role of the serotonergic system in the forced swimming test. Neurosci. Biobehav. Rev. 19 (1995) 377-395
5. Borsini F., and Meli A. Is the forced swimming test a suitable model for revealing antidepressant activity?. Psychopharmacology 94 (1988) 147-160
6. Borsini F., Podhorna J., and Marazziti D. Do animal models of anxiety predict anxiolytic-like effects of antidepressants?. Psychopharmacology 163 (2002) 121-141
7. 7 receptor-mediated depolarization in the anterodorsal thalamus. II. Involvement of the hyperpolarization-activated current I(h). J. Pharmacol. Exp. Ther. 297 (2001) 403-409
8. Chojnacka-Wójcik E., Kłodzińska A., and Pilc A. Glutamate receptor ligands as anxiolytics. Curr. Opin. Investig. Drugs 2 (2001) 1112-1119
9. 7 receptor antagonist. J. Med. Chem. 41 (1998) 655-657
10. 7 receptors modulate synchronized network activity in rat hippocampus. Neuropharmacology 42 (2002) 82-92
11. 7 receptor. Neuropharmacology 44 (2003) 1031-1037
12. 7 receptor suggest therapeutic potential in depression. Neuropharmacology 48 (2005) 492-502
13. 7 receptor in rat brain. Br. J. Pharmacol. 117 (1996) 657-666
14. 7 receptor antagonist. Br. J. Pharmacol. 130 (2000) 539-548
15. 3H]serotonin release in raphe nuclei slices of the rat: evidence for a serotonergic-glutamatergic interaction. Neurochem. Res. 29 (2004) 1487-1497
16. 7 receptor research. Trends Pharmacol. Sci. 25 (2004) 481-486
17. 7 receptor knockout mice. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 1375-1380
18. 7 receptors to induce hypothermia in rodents. Eur. J. Pharmacol. 487 (2004) 125-132
19. 7 receptor inhibition and inactivation induce antidepressant-like behavior and sleep pattern. Biol. Psychiatry 58 (2005) 831-837
20. 7) receptor isoforms produced by alternative splicing. Neuropharmacology 37 (1998) 1621-1632
21. Hensler J.G. Serotonergic modulation of the limbic system. Neurosci. Biobehav. Rev. 30 (2006) 203-214
22. Hoyer D., and Martin G. 5-HT receptor classification and nomenclature: towards a harmonization with the human genome. Neuropharmacology 36 (1997) 419-428
23. Janssen P.A.J., Jagenau A.H.M., and Schellekens K.H.C. Chemistry and pharmacology of compound related to 4-(4-hydroxy-4-phenylpiperidino)-butyrophenone. IV: Influence of haloperidol (R-1625) and chloropromazine on the behaviour of rats in an unfamiliar open field situation. Psychopharmacology 1 (1960) 389-392
24. 7 receptor. J. Med. Chem. 42 (1999) 533-535
25. Kostowski W. Possible relationship of the locus coeruleus-hippocampal noradrenergic neurons to depression and mode of action of antidepressant drugs. Pol. J. Pharmacol. Pharm. 37 (1985) 727-743
26. 7 antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)-ethyl)pyrrolidine-1-sulfonyl)phenol (SB-269970). J. Med. Chem. 43 (2000) 342-345
27. 7 receptors. Eur. J. Pharmacol. 495 (2004) 97-102
28. 3H]mesulergine: comparison to other mammalian species. Br. J. Pharmacol. 141 (2004) 92-104
29. Matsumoto M., Kojima T., Togashi H., Mori K., Ohashi S., Ueno K., and Yoshioka M. Differential characteristics of endogenous serotonin-mediated synaptic transmission in the hippocampal CA1 and CA3 fields of aesthetized rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 366 (2002) 570-577
30. 7 receptor antagonists SB-269970 and DR 4004 in autoshaping Pavlovian/instrumental learning task. Behav. Brain Res. 155 (2004) 275-282
31. Millan M.J. The neurobiology and control of anxious states. Prog. Neurobiol. 70 (2003) 83-244
32. 7 receptor regulation in the rat hypothalamus. Neuropsychopharmacology 21 (1999) 352-367
33. Nestler E.J., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., and Monteggia L.M. Neurobiology of depression. Neuron 34 (2002) 13-25
34. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1982), Academic Press, Sydney
35. Porsolt R.D., Anton G., Blavet N., and Jalfre M. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur. J. Pharmacol. 47 (1978) 379-391
36. Przegaliński E., Tatarczyńska E., Dereń-Wesołek A., and Chojnacka-Wójcik E. Antidepressant-like effects of a partial agonist at strychnine-insensitive glycine receptors and a competitive NMDA receptor antagonist. Neuropharmacology 36 (1997) 31-37
37. 7 receptors show specific impairments in contextual learning. Eur. J. Neurosci. 19 (2004) 1913-1922
38. 7 receptor-mediated effects on 5-HT efflux in the guinea-pig dorsal raphe nucleus. Neuropharmacology 46 (2004) 935-941
39. Roth B.L., Craigo S.C., Choudhary M.S., Uluer A., Monsma Jr.F.J., Shen Y., Meltzer H.Y., and Sibley D.R. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J. Pharmacol. Exp. Ther. 268 (1994) 1403-1410
40. 7) activating cAMP formation. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 8547-8551
41. Saudou F., and Hen R. 5-Hydroxytryptamine receptor subtypes: molecular and functional diversity. Adv. Pharmacol. 30 (1994) 327-380
42. 7 serotonin receptor subtype. J. Biol. Chem. 268 (1993) 18200-18204
43. Sherman A.D., and Allers G.L. Relationship between regional distribution of imipramine and its effect on learned helplessness in the rat. Neuropharmacology 19 (1980) 159-162
44. 7 receptor binding sites in rat hypothalamus: sensitivity to chronic antidepressant treatment. Mol. Pharmacol. 47 (1995) 99-103
45. 7 receptors. Curr. Drug Targets - CNS Neurol. Disord. 3 (2004) 81-90
46. 1A receptors. Br. J. Pharmacol. 128 (1999) 158-164
47. 7 receptors increase the excitability of rat hippocampal CA1 pyramidal neurons. Brain Res. 993 (2003) 230-234
48. 7 receptors. Eur. J. Pharmacol. 524 (2005) 60-66
49. 3H]SB-269970. Neurosci. Lett. 367 (2004) 313-316
50. Vogel J.R., Beer B., and Clody D.E. A simple and reliable conflict procedure for testing anti-anxiety agents. Psychopharmacologia 21 (1971) 1-7
51. Vythilingam M., Vermetten E., Anderson G.M., Luckenbaugh D., Anderson E.R., Snow J., Staib L.H., Charney D.S., and Bremner J.D. Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment. Biol. Psychiatry 56 (2004) 101-112
52. 7 receptor antagonist SB 269970 in animal models of anxiety and depression. Neuropharmacology 51 (2006) 578-586
53. 7 receptor mRNA expression in the rat hippocampus. Neurosci. Lett. 309 (2001) 141-144